Business Wire

Ncardia Signs License Agreement with First Pharmaceutical Partner for Disease Modeling Patent Portfolio

Del

Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate companies gain access to key disease modeling patents from Ncardia.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171012006114/en/

Ncardia is a leader in standardized, validated iPSC assays for safety, phenotypic screening and dise ...

Ncardia is a leader in standardized, validated iPSC assays for safety, phenotypic screening and disease modeling. For scientists conducting cardiovascular and neural safety and efficacy projects, Ncardia is providing tools to facilitate accelerated development of drugs, while replacing animal studies and putting a "human" aspect back into drug discovery. (Graphic: Business Wire)

Ncardia was recently formed through the merger of Axiogenesis and Pluriomics. The two companies have pioneered the development of stem cell derived cells for drug discovery and safety and in particular have advanced disease and tissue modeling applications.

The Ncardia patent portfolio consists of several granted patents in Europe, the USA and Japan. The drug screening and disease modeling technology not only involves patient iPSC cells, induction of the disease phenotype can also be achieved through genetic manipulation, mRNA or siRNA transfection or through chemical or physical induction.

Dr Stefan Braam, CEO Ncardia, commented: “Ncardia mission is to support and enable our clients to make better medicines faster. The combination of iPSC derived disease models with phenotypic screening is an extremely powerful method to identify new drug candidates. This license marks a further step in Ncardia technology strategy aimed at addressing the potential of stem cell applications in the drug discovery and development market."

Roche has now obtained a non-exclusive, worldwide license to the key Ncardia disease modeling patents claiming the use of stem cell derived cells disease models for the discovery & development of novel drug candidates. The financial terms of the agreements are not disclosed.

“This license is the first step of our strategy to make our technology available to the pharmaceutical drug discovery & development market.” Felix von Haniel VP Sales and BD of Ncardia. In addition to disease modeling applications Ncardia is committed to providing the most predictive healthy human cellular models to improve and accelerate safety testing.

Ncardia: Ncardia (www.ncardia.com) believes that stem cell technology will help to get better medicines to patients faster. The company develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The cardiac product portfolio encompasses a broad panel of hiPSC derived Cardiomyocytes (Pluricyte®, Cor.4U® and vCor.4U) as well cardiac fibroblasts (FibroCor.4U). In addition, the company delivers the Cardioplate product line of quality controlled ready to use assay plates. The neural cell portfolio contains the pan-neuronal product CNS.4U®, the peripheral neurons product Peri.4U®, and astrocyte product Astro.4U®.

Ncardia is committed to deliver its clients working assays solutions through in house assay development and extensive support. The company has a wide range of supported applications and compound assay services such as of electrophysiology, biochemistry and contraction based assays for predictive safety pharmacology and toxicology testing. In addition, Ncardia develops and provides its customers with a broad portfolio of cardiovascular services from disease modeling to cardiovascular drug efficacy screening.

Ncardia is based in Belgium, the Netherlands, Germany and in the USA. The company is privately held and established following the merger of Pluriomics and Axiogenesis.

Contact information

Media:
Ncardia
Felix von Haniel
felix.haniel@ncardia.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Robinson Fresh® and Verfrut Bring Premium Fruit to Europe21.2.2018 04:00Pressemelding

Robinson Fresh®, a division of C.H. Robinson, is now the primary provider of Verfrut products in Europe. Verfrut is one of the largest fruit growers in South America with items such as grapes, apples, stone fruit, cherries, pears, kiwifruit, clementines and organic bananas. With this strategic alliance, the companies bring together expertise in cold chain logistics and produce to provide a more integrated fruit offering to Europeans. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180220006476/en/ “When we heard Verfrut was looking for opportunities to expand into the European market, we knew we could work together to bring these premium products to our customers,” Robert Walsleben, European director for Robinson Fresh, said. “Verfrut is one of the largest fruit growers out of Chile and Peru. They are also family owned, feature significant production and care about providing flavorful products to their customers. Europeans wil

Bigelow Space Operations Announces Partnership with CASIS to Fly Payloads to the International Space Station21.2.2018 00:18Pressemelding

Bigelow Space Operations (BSO) is proud to announce a partnership with the Center for the Advancement of Science in Space (CASIS), manager of the International Space Station (ISS) U.S. National Laboratory. BSO is officially a user of the ISS National Lab, and will be facilitating the integration of payloads for commercial, academic and government customers. In this capacity, BSO intends to contract with other payload integrating companies where we not only can help those companies to develop their dynamic futures for themselves and their successful clients extending beyond ISS operations, but to also offer ourselves as a customer and understand how to help CASIS. This may be important if CASIS is to someday enable usage of B330 stations. BSO’s mandate is to promote the services of the ISS National Lab, promote other payload facilitating companies and to develop new relationships for the ISS and Bigelow Aerospace stations. BSO will kick off this through a recently awarded CASIS partner

Bigelow Aerospace Announces the Creation of Bigelow Space Operations20.2.2018 22:00Pressemelding

Bigelow Aerospace is excited to introduce Bigelow Space Operations (BSO), a new commercial space company that is the sales, operational and customer service company that manages and operates space stations developed by Bigelow Aerospace. With the two launches of B330-1 and B330-2 expected in 2021, the time is now in 2018 to begin BSO activity. These single structures that house humans on a permanent basis will be the largest, most complex structures ever known as stations for human use in space. The customers that B330 will seek to accommodate will be very diverse. Bigelow Space Operations has a mission to market and operate these and other space stations including future generations developed by Bigelow Aerospace that are so capable, so diverse and so large that they can accommodate virtually unlimited use almost anywhere. Over time, Bigelow Aerospace will manufacture a single station, launched on a single rocket that will contain over 2.4 times the pressurized volume of the entire In

Andersen Tax & Legal Launches in Egypt20.2.2018 14:30Pressemelding

The Andersen name launches in Egypt this week as Maher Milad Iskander and Co., an Egyptian tax and legal firm based in Cairo, formally adopts the name Andersen Tax & Legal. Maher Milad Iskander and Co. became a collaborating firm of Andersen Global in July of 2017 and is one of three that have become member firms and adopted the Andersen name thus far in 2018. Maher Milad Iskander, Managing Partner of Andersen Tax & Legal in Egypt, said, “Andersen Global’s strategy of focusing on outstanding tax and legal services will provide us with many advantages and will allow us to even better serve our cross-border clientele. We are looking forward to our continued work with the Andersen team and to seamlessly providing innovative and client-focused solutions on a global level through our colleagues around the world.” “Egypt is considered to be one of the highest growing markets in the world and our adoption of the Andersen name in Egypt has come at the perfect time,” added Global Chairman and A

Proposals of the Supervisory Board to Be Submitted to the Annual General Shareholders' Meeting of Sartorius AG20.2.2018 14:00Pressemelding

At today’s meeting, the Supervisory Board of Sartorius AG, approved the Executive Board’s recommendation to submit a proposal to the Annual General Shareholders’ Meeting on April 5, 2018, to raise dividends to 0.51 euros per preference share and 0.50 euros per ordinary share. Prior-year dividends were 0.46 euros and 0.45 euros per preference share and per ordinary share, respectively. Therefore, the total amount disbursed under this proposal would increase by 11.0% to 34.5 million euros from 31.1 million euros a year earlier. In addition, the Supervisory Board will submit a proposal to the Annual General Shareholders’ Meeting to elect Dr. Guido Oelkers to the Supervisory Board as a representative of the shareholders. Guido Oelkers has already been a member of this board since November 2017. He was appointed by court order after Supervisory Board member Professor Arnold Picot, Ph.D., had passed away. Guido Oelkers, who was born in 1965 and holds a university degree in business administr

ETECSA Enhances Connectivity to the Rest of the World with SES Networks20.2.2018 14:00Pressemelding

Cubans and visitors to Cuba will have additional access to reliable and uninterrupted connectivity throughout the main island of Cuba as ETECSA, Cuba’s national telecommunications operator, signed a deal with SES Networks for satellite services, SES announced today. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180220005894/en/ ETECSA Enhances Connectivity to the Rest of the World with SES Networks (Photo: Business Wire) SES Networks will augment ETECSA’s existing terrestrial infrastructure with its high-performance fibre-like medium earth orbit (MEO) capacity and improve connectivity for end-customers of the Cuban operator. “By working with SES Networks, we are ensuring that our customers across the main island will have a new way to access high-performing Internet at all times through this innovative satellite system. Our collaboration with SES Networks highlights ETECSA’s mission of providing telecommunications services t